TMS-related Measures as Biomarker of Cognitive Impairment in PD
Recruiting
N/A
Interventional Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 52 (estimated)
- Sponsor
- Azienda Sanitaria Universitaria Integrata del Trentino · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of the present study is to explore the diagnostic and prognostic value of neurophysiological biomarkers obtained through paired-pulse Transcranial Magnetic Stimulation (TMS) techniques in individuals affected by Parkinson's disease (PD) with and without cognitive decline.
The main questions it aims to answer are:
* TMS measures of cortical excitability are able to distinguish between PD…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* Ability to undergo an extensive neuropsychological evaluation
* Ability to sign informed consent for the study
* Diagnosed with idiopathic PD according to the latest revision of the MDS criteria
* On stable and optimal antiparkinsonian therapy for at least fo…
Contacts